BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38745208)

  • 1. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
    Raj-Kumar PK; Lin X; Liu T; Sturtz LA; Gritsenko MA; Petyuk VA; Sagendorf TJ; Deyarmin B; Liu J; Praveen-Kumar A; Wang G; McDermott JE; Shukla AK; Moore RJ; Monroe ME; Webb-Robertson BM; Hooke JA; Fantacone-Campbell L; Mostoller B; Kvecher L; Kane J; Melley J; Somiari S; Soon-Shiong P; Smith RD; Mural RJ; Rodland KD; Shriver CD; Kovatich AJ; Hu H
    Breast Cancer Res; 2024 May; 26(1):76. PubMed ID: 38745208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
    Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
    J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated multi-omics characterization of KRAS mutant colorectal cancer.
    Chong W; Zhu X; Ren H; Ye C; Xu K; Wang Z; Jia S; Shang L; Li L; Chen H
    Theranostics; 2022; 12(11):5138-5154. PubMed ID: 35836817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated proteogenomic characterization of urothelial carcinoma of the bladder.
    Xu N; Yao Z; Shang G; Ye D; Wang H; Zhang H; Qu Y; Xu F; Wang Y; Qin Z; Zhu J; Zhang F; Feng J; Tian S; Liu Y; Zhao J; Hou J; Guo J; Hou Y; Ding C
    J Hematol Oncol; 2022 Jun; 15(1):76. PubMed ID: 35659036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
    Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
    Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating proteomic and phosphoproteomic data for pathway analysis in breast cancer.
    Ren J; Wang B; Li J
    BMC Syst Biol; 2018 Dec; 12(Suppl 8):130. PubMed ID: 30577793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes.
    Kumar N; Zhao D; Bhaumik D; Sethi A; Gann PH
    BMC Cancer; 2019 Mar; 19(1):215. PubMed ID: 30849944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteogenomics connects somatic mutations to signalling in breast cancer.
    Mertins P; Mani DR; Ruggles KV; Gillette MA; Clauser KR; Wang P; Wang X; Qiao JW; Cao S; Petralia F; Kawaler E; Mundt F; Krug K; Tu Z; Lei JT; Gatza ML; Wilkerson M; Perou CM; Yellapantula V; Huang KL; Lin C; McLellan MD; Yan P; Davies SR; Townsend RR; Skates SJ; Wang J; Zhang B; Kinsinger CR; Mesri M; Rodriguez H; Ding L; Paulovich AG; Fenyö D; Ellis MJ; Carr SA;
    Nature; 2016 Jun; 534(7605):55-62. PubMed ID: 27251275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study.
    Olivier M; Bouaoun L; Villar S; Robitaille A; Cahais V; Heguy A; Byrnes G; Le Calvez-Kelm F; Torres-Mejía G; Alvarado-Cabrero I; Imani-Razavi FS; Inés Sánchez G; Jaramillo R; Porras C; Rodriguez AC; Garmendia ML; Soto JL; Romieu I; Porter P; Guenthoer J; Rinaldi S;
    PLoS One; 2019; 14(1):e0210372. PubMed ID: 30653559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
    Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
    Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.
    Madera S; Chervo MF; Chiauzzi VA; Pereyra MG; Venturutti L; Izzo F; Roldán Deamicis A; Guzman P; Dupont A; Roa JC; Cenciarini ME; Barchuk S; Figurelli S; Lopez Della Vecchia D; Levit C; Lebersztein G; Anfuso F; Castiglioni T; Cortese E; Ares S; Deza EG; Gercovich FG; Proietti CJ; Schillaci R; Cordo Russo RI; Elizalde PV
    Horm Cancer; 2020 Oct; 11(5-6):218-239. PubMed ID: 32632815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.
    Watson J; Wang T; Ho KL; Feng Y; Mahawan T; Dobbin KK; Zhao S
    Breast Cancer Res; 2023 Oct; 25(1):114. PubMed ID: 37789381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.
    Vasaikar S; Huang C; Wang X; Petyuk VA; Savage SR; Wen B; Dou Y; Zhang Y; Shi Z; Arshad OA; Gritsenko MA; Zimmerman LJ; McDermott JE; Clauss TR; Moore RJ; Zhao R; Monroe ME; Wang YT; Chambers MC; Slebos RJC; Lau KS; Mo Q; Ding L; Ellis M; Thiagarajan M; Kinsinger CR; Rodriguez H; Smith RD; Rodland KD; Liebler DC; Liu T; Zhang B;
    Cell; 2019 May; 177(4):1035-1049.e19. PubMed ID: 31031003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.
    Wang L; Wrobel JA; Xie L; Li D; Zurlo G; Shen H; Yang P; Wang Z; Peng Y; Gunawardena HP; Zhang Q; Chen X
    Cell Chem Biol; 2018 May; 25(5):619-633.e5. PubMed ID: 29503206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes.
    Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS
    Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):725-34. PubMed ID: 24521998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
    Sabatier R; Finetti P; Guille A; Adelaide J; Chaffanet M; Viens P; Birnbaum D; Bertucci F
    Mol Cancer; 2014 Oct; 13():228. PubMed ID: 25277734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
    Aftimos P; Oliveira M; Irrthum A; Fumagalli D; Sotiriou C; Gal-Yam EN; Robson ME; Ndozeng J; Di Leo A; Ciruelos EM; de Azambuja E; Viale G; Scheepers ED; Curigliano G; Bliss JM; Reis-Filho JS; Colleoni M; Balic M; Cardoso F; Albanell J; Duhem C; Marreaud S; Romagnoli D; Rojas B; Gombos A; Wildiers H; Guerrero-Zotano A; Hall P; Bonetti A; Larsson KF; Degiorgis M; Khodaverdi S; Greil R; Sverrisdóttir Á; Paoli M; Seyll E; Loibl S; Linderholm B; Zoppoli G; Davidson NE; Johannsson OT; Bedard PL; Loi S; Knox S; Cameron DA; Harbeck N; Montoya ML; Brandão M; Vingiani A; Caballero C; Hilbers FS; Yates LR; Benelli M; Venet D; Piccart MJ
    Cancer Discov; 2021 Nov; 11(11):2796-2811. PubMed ID: 34183353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer Patients.
    Koçak A; Heselmeyer-Haddad K; Lischka A; Hirsch D; Fiedler D; Hu Y; Doberstein N; Torres I; Chen WD; Gertz EM; Schäffer AA; Freitag-Wolf S; Kirfel J; Auer G; Habermann JK; Ried T
    Am J Pathol; 2020 Aug; 190(8):1643-1656. PubMed ID: 32416097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.